Ten-year follow-up of a randomized controlled trial of adjuvant clodronate treatment in node-positive breast cancer patients

By Saarto Tiina   Vehmanen Leena   Virkkunen Pekka   Blomqvist Carl  

Acta Oncologica, Vol. 43, Iss. 7, 2004-10 ,pp. : 650-656

Informa Healthcare

Access to resources Recommend Favorite

A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up

By Walshe Janice   Berman Arlene   Vatas Ujala   Steinberg Seth   Anderson William   Lippman Marc   Swain Sandra  

Breast Cancer Research and Treatment, Vol. 103, Iss. 2, 2007-06 ,pp. : 177-183

Springer Publishing Company

Access to resources Recommend Favorite

Upregulation of HER-2/neu by Ovarian Ablation: Results of a Randomized Trial Comparing Leuprorelin to CMF as Adjuvant Therapy in Node-positive Breast Cancer Patients

By Lüftner D.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 245-255

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Follow-Up of a Phase II Trial Studying a Weekly Doxorubicin-Based Multiple Drug Adjuvant Therapy for Stage II Node-Positive Carcinoma of the Breast

By Kimmick Gretchen   Shelton Brent   Case L.   Cooper M.   Muss Hyman  

Breast Cancer Research and Treatment, Vol. 72, Iss. 3, 2002-04 ,pp. : 233-243

Springer Publishing Company

Access to resources Recommend Favorite

E2F1 Expression is Related with the Poor Survival of Lymph Node-positive Breast Cancer Patients Treated with Fluorouracil, Doxorubicin and Cyclophosphamide

By Han Sehwan  

Breast Cancer Research and Treatment, Vol. 82, Iss. 1, 2003-01 ,pp. : 11-16

Springer Publishing Company

Access to resources Recommend Favorite